Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Current Opinion in Urology|October 16, 2003
Basic science and research in renal cell carcinoma: from workbench to bedsideAxel Heidenreich, Andres J Schrader, Zoltan VargaJournal of Clinical Medicine|July 14, 2023
A New Proximal Adjustable Sling ATOMS SSP® Implantation Technique with Focus on the Urethral Bulb: Lessons Learned from Revision SurgeryFabian Queissert, Benedict Bruecher, Andres J SchraderInternational Urogynecology Journal|March 1, 2022
Supratrigonal cystectomy and augmentation cystoplasty with ileum or ileocecum in the treatment of ulcerative interstitial cystitis/bladder pain syndrome: a 14-year follow-upFabian Queissert, Benedict Bruecher, Arndt van Ophoven, et al.Oncotarget|April 27, 2017
Influence of serum cholesterol level and statin treatment on prostate cancer aggressivenessThomas J Schnoeller, Florian Jentzmik, Andres J Schrader, et al.Urology|November 29, 2008
Simultaneous adrenalectomy during radical nephrectomy for renal cell carcinoma will not cure patients with adrenal metastasisRolf von Knobloch, Andres J Schrader, Eduard M Walthers, et al.International Urology and Nephrology|March 20, 2015
Do preoperative serum C-reactive protein levels predict the definitive pathological stage in patients with clinically localized prostate cancer?Thomas J Schnoeller, Julie Steinestel, Konrad Steinestel, et al.Urological Research|September 6, 2007
Pre- and perioperative predictors of short-term clinical outcomes in patients undergoing percutaneous nephrolitholapaxyPeter J Olbert, Axel Hegele, Andres J Schrader, et al.Anti-Cancer Drugs|October 1, 2004
Application of retinoids in the treatment of renal cell carcinoma--a futile effort?Andres J Schrader, Rolf von Knobloch, Axel Heidenreich, et al.BJU International|February 5, 2008
Metastatic non-clear cell renal cell carcinoma: current therapeutic optionsAndres J Schrader, Peter J Olbert, Axel Hegele, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Molecular serological detection of DNA alterations in transitional cell carcinoma is highly sensitive and stage independentRolf von Knobloch, Heidrun Brandt, Andres J Schrader, et al.Pageof 7